Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/212597 |
Resumo: | Abstract Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) widely used to treat rheumatoid arthritis and other inflammatory diseases. Normally used by oral route, this drug presents numerous side effects related to this administration route, such as nausea, dyspepsia, diarrhea, constipation and even renal complications. To avoid that, topical administration of ketoprofen represents a good alternative, since this drug has both partition coefficient and aqueous solubility suitable for skin application, compared to other NSAIDs. In this study, we describe the production of a nanoemulsion containing ketoprofen, its skin permeation and in vitro release study and a novel validation method to analyze this drug in the permeation samples and a forced degradation study using skin and nanoemulsion samples. The new HPLC method was validated, with all specifications in accordance with validation parameters and with an easy chromatographic condition. Forced degradation study revealed that ketoprofen is sensitive to acid and basic hydrolysis, developing degradation peaks after exposure to these factors. Concerning in vitro release from the nanoemulsion, release curves presented first order profile and were not similar to each other. After 8 h, 85% of ketoprofen was release from the nanoemulsion matrix while 49% was release from control group. In skin permeation study, nanoemulsion enabled ketoprofen to pass through the skin and enhanced retention in the epidermis and stratum corneum, layer on which the formulation presented statistically different values compared to the control group. |
id |
UFRGS-2_a05a0014a17fc69b6f0c7c7c57cb9af6 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/212597 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Lucca, Letícia GrolliMatos, Sheila Porto deWeimer, PatríciaTeixeira, Helder FerreiraKoester, Leticia Scherer2020-08-04T03:39:14Z20201878-5352http://hdl.handle.net/10183/212597001115537Abstract Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) widely used to treat rheumatoid arthritis and other inflammatory diseases. Normally used by oral route, this drug presents numerous side effects related to this administration route, such as nausea, dyspepsia, diarrhea, constipation and even renal complications. To avoid that, topical administration of ketoprofen represents a good alternative, since this drug has both partition coefficient and aqueous solubility suitable for skin application, compared to other NSAIDs. In this study, we describe the production of a nanoemulsion containing ketoprofen, its skin permeation and in vitro release study and a novel validation method to analyze this drug in the permeation samples and a forced degradation study using skin and nanoemulsion samples. The new HPLC method was validated, with all specifications in accordance with validation parameters and with an easy chromatographic condition. Forced degradation study revealed that ketoprofen is sensitive to acid and basic hydrolysis, developing degradation peaks after exposure to these factors. Concerning in vitro release from the nanoemulsion, release curves presented first order profile and were not similar to each other. After 8 h, 85% of ketoprofen was release from the nanoemulsion matrix while 49% was release from control group. In skin permeation study, nanoemulsion enabled ketoprofen to pass through the skin and enhanced retention in the epidermis and stratum corneum, layer on which the formulation presented statistically different values compared to the control group.application/pdfengArabian journal of chemistry. Amesterdam. Vol. 13, n. 2 (Feb. 2020), p. 4505-4511FarmáciaCetoprofenoValidationForced degradationNanoemulsionImproved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsionEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001115537.pdf.txt001115537.pdf.txtExtracted Texttext/plain27366http://www.lume.ufrgs.br/bitstream/10183/212597/2/001115537.pdf.txt21dd5e816bfe3cfba805d00fb20893d9MD52ORIGINAL001115537.pdfTexto completo (inglês)application/pdf879223http://www.lume.ufrgs.br/bitstream/10183/212597/1/001115537.pdf6ca1743dec79cef02651fb11292076aeMD5110183/2125972022-08-12 04:49:26.584737oai:www.lume.ufrgs.br:10183/212597Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2022-08-12T07:49:26Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion |
title |
Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion |
spellingShingle |
Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion Lucca, Letícia Grolli Farmácia Cetoprofeno Validation Forced degradation Nanoemulsion |
title_short |
Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion |
title_full |
Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion |
title_fullStr |
Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion |
title_full_unstemmed |
Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion |
title_sort |
Improved skin delivery and validation of novel stability-indicating HPLC method for ketoprofen nanoemulsion |
author |
Lucca, Letícia Grolli |
author_facet |
Lucca, Letícia Grolli Matos, Sheila Porto de Weimer, Patrícia Teixeira, Helder Ferreira Koester, Leticia Scherer |
author_role |
author |
author2 |
Matos, Sheila Porto de Weimer, Patrícia Teixeira, Helder Ferreira Koester, Leticia Scherer |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Lucca, Letícia Grolli Matos, Sheila Porto de Weimer, Patrícia Teixeira, Helder Ferreira Koester, Leticia Scherer |
dc.subject.por.fl_str_mv |
Farmácia Cetoprofeno |
topic |
Farmácia Cetoprofeno Validation Forced degradation Nanoemulsion |
dc.subject.eng.fl_str_mv |
Validation Forced degradation Nanoemulsion |
description |
Abstract Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) widely used to treat rheumatoid arthritis and other inflammatory diseases. Normally used by oral route, this drug presents numerous side effects related to this administration route, such as nausea, dyspepsia, diarrhea, constipation and even renal complications. To avoid that, topical administration of ketoprofen represents a good alternative, since this drug has both partition coefficient and aqueous solubility suitable for skin application, compared to other NSAIDs. In this study, we describe the production of a nanoemulsion containing ketoprofen, its skin permeation and in vitro release study and a novel validation method to analyze this drug in the permeation samples and a forced degradation study using skin and nanoemulsion samples. The new HPLC method was validated, with all specifications in accordance with validation parameters and with an easy chromatographic condition. Forced degradation study revealed that ketoprofen is sensitive to acid and basic hydrolysis, developing degradation peaks after exposure to these factors. Concerning in vitro release from the nanoemulsion, release curves presented first order profile and were not similar to each other. After 8 h, 85% of ketoprofen was release from the nanoemulsion matrix while 49% was release from control group. In skin permeation study, nanoemulsion enabled ketoprofen to pass through the skin and enhanced retention in the epidermis and stratum corneum, layer on which the formulation presented statistically different values compared to the control group. |
publishDate |
2020 |
dc.date.accessioned.fl_str_mv |
2020-08-04T03:39:14Z |
dc.date.issued.fl_str_mv |
2020 |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/212597 |
dc.identifier.issn.pt_BR.fl_str_mv |
1878-5352 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001115537 |
identifier_str_mv |
1878-5352 001115537 |
url |
http://hdl.handle.net/10183/212597 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Arabian journal of chemistry. Amesterdam. Vol. 13, n. 2 (Feb. 2020), p. 4505-4511 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/212597/2/001115537.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/212597/1/001115537.pdf |
bitstream.checksum.fl_str_mv |
21dd5e816bfe3cfba805d00fb20893d9 6ca1743dec79cef02651fb11292076ae |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447718346096640 |